Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Privia Health (PRVA) Cost of Revenue (2020 - 2025)

Historic Cost of Revenue for Privia Health (PRVA) over the last 6 years, with Q3 2025 value amounting to $7.0 million.

  • Privia Health's Cost of Revenue fell 123.46% to $7.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $27.1 million, marking a year-over-year increase of 349.18%. This contributed to the annual value of $26.4 million for FY2024, which is 693.03% up from last year.
  • Latest data reveals that Privia Health reported Cost of Revenue of $7.0 million as of Q3 2025, which was down 123.46% from $6.8 million recorded in Q2 2025.
  • In the past 5 years, Privia Health's Cost of Revenue registered a high of $11.2 million during Q2 2021, and its lowest value of $3.2 million during Q1 2021.
  • In the last 5 years, Privia Health's Cost of Revenue had a median value of $6.1 million in 2024 and averaged $6.0 million.
  • In the last 5 years, Privia Health's Cost of Revenue soared by 40351.35% in 2021 and then plummeted by 5688.85% in 2022.
  • Quarter analysis of 5 years shows Privia Health's Cost of Revenue stood at $3.8 million in 2021, then soared by 36.13% to $5.2 million in 2022, then increased by 20.8% to $6.2 million in 2023, then grew by 3.41% to $6.5 million in 2024, then grew by 7.71% to $7.0 million in 2025.
  • Its Cost of Revenue was $7.0 million in Q3 2025, compared to $6.8 million in Q2 2025 and $6.9 million in Q1 2025.